Browsing by Subject "A61K 2039/55516"
Now showing items 1-8 of 8
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-12-10)Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-06-26)Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-01-05)Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2011-12-06)The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-06-29)The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2006-07-18)The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2007-10-09)The present invention involves a recombinant virus which comprises at least one foreign nucleic acid inserted within a non-essential region of the viral genome of a virus, wherein each such foreign nucleic acid encodes a ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-06-16)Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...